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Summary
 
‘Mitochondrial dysfunction’, which may result from an
accumulation of damaged mitochondria in cells due to
a slowed-down rate of mitochondrial turnover and
inadequate removal of damaged mitochondria during aging,
has been implicated as both cause and consequence of the
aging process and a number of age-related pathologies.
Despite growing interest in mitochondrial function during
aging, published data on mitochondrial turnover are
scarce, and differ from each other by up to one order of
magnitude. Here we demonstrate that re-utilization of
the radioactively labelled precursor in pulse-chase assays
is the most likely cause of significant overestimation of
mitochondrial turnover rates. We performed a classic
radioactive label pulse-chase experiment using 
 
14
 
C NaHCO
 
3
 
,
whose 
 
14
 
C is incorporated into various amino acids, to
measure mitochondrial turnover in mouse liver. In this
system, the activity of the urea cycle greatly limited
arginine dependent label re-utilization, but not that of
other amino acids. We used information from tissues that do
not have an active urea cycle (brain and muscle) to estimate
the extent of label re-utilization with a dynamic mathe-
matical model. We estimated the actual liver mitochondrial
half life as only 1.83 days, and this decreased to 1.16 days
following 3 months of dietary restriction, supporting the
hypothesis that this intervention might promote mito-
chondrial turnover as a part of its beneficial effects.
Key words: dietary restriction; half life; liver; mathematical
model; mitochondria; mice; turnover.
 
Recent years have seen a surge of interest in the role of mito-
chondrial dysfunction, reactive oxygen species production and
mitochondrial DNA mutation as driving factors in the aging
process (Balaban 
 
et
 
 
 
al
 
., 2005; Trifunovic 
 
et
 
 
 
al
 
., 2005; Bender
 
et
 
 
 
al
 
., 2006; Passos 
 
et
 
 
 
al
 
., 2007). Damaged mitochondria might
accumulate in cells due to a slowed-down turnover with aging
(de Grey, 1997; Kowald & Kirkwood, 2000; Terman & Brunk,
2005). Conversely, it was proposed that the ‘anti-aging’
function of dietary restriction (DR) might be at least partially
due to stimulation of molecular and, specifically, mitochondrial
turnover (Donati 
 
et
 
 
 
al
 
., 2001; Bergamini 
 
et
 
 
 
al
 
., 2003; Del Roso
 
et
 
 
 
al
 
., 2003; Cuervo 
 
et
 
 
 
al
 
., 2005). Surprisingly, essentially all
information on mitochondrial turnover relies on data that
are not only at least 20 years old but that vary by one order of
magnitude between different estimates. These differences are
largely methodological. Mitochondrial protein degradation is
generally measured by radio-isotope pulse-chase assay to
calculate the rate constant of degradation (and so the half life),
assuming that the data follow a simple exponential decay. Label
re-utilization (i.e. the re-incorporation of labelled precursor arising
from broken down products of the pulse-labelled protein) can
be a major problem with this approach, leading to significant
lengthening of the apparent half life. An ideal precursor would
allow fast protein labelling (i.e. the level of the specific activity
of the precursor pool should quickly decrease to zero) thereby
avoiding label re-utilization. In essence, the best precursor will
give the shortest half life estimate.
Labelling of liver mitochondria with 
 
14
 
C NaHCO
 
3
 
 (which is
converted to arginine in the liver) (Lipsky & Pedersen, 1981;
Lavie 
 
et
 
 
 
al
 
., 1982; Saikumar & Kurup, 1985) or 
 
14
 
C arginine
(Aschenbrenner 
 
et
 
 
 
al
 
., 1970; Gross, 1971; Glass & Doyle, 1972)
has consistently given the shortest half life in contrast to the
use of other amino acid precursors, suggesting that label re-
utilization of non-arginine amino acid precursors was a major
problem. This is because 
 
14
 
C NaHCO
 
3
 
  is converted to 
 
14
 
C
arginine (the 
 
14
 
C label being in the guanidine position; 6-
 
14
 
C
arginine) in the liver through urea cycle activity, while NaHCO
 
3
 
turnover is fast 
 
in vivo
 
 and the specific activity of 
 
14
 
C NaHCO
 
3
 
decreases rapidly (Millward, 1970). Re-utilization of labelled
arginine is minimized by the high activity of arginase found in
the liver, which quickly decomposes arginine into urea (which
inherits the labelled 
 
14
 
C) that is readily excreted. Unlike 
 
14
 
C
arginine, 
 
14
 
C NaHCO
 
3
 
  will not substantially label proteins in
nonhepatic tissues and can thus avoid 
 
14
 
C label re-utilization of
broken down products deriving from nonhepatic tissues.
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However, in a standard 
 
14
 
C NaHCO
 
3
 
 pulse-chase protocol as
described by Lipsky & Pedersen (1981, 1982) (Fig. 1A), we still
found evidence for label re-utilization: the fit of a single
exponential decay curve to the data was not good. In particular,
using this model, the estimated half lives increased systematically
if later time points were included in the data set (Fig. 1B). In
addition, when comparing DR animals to controls, the estimated
half lives appeared faster or slower depending on the length
of the chase period (Fig. 1B). This indicated that the decay in
specific activity of 
 
14
 
C in liver mitochondria followed a more
complex pattern consisting of a fast component, which is the
degradation of mitochondrial 6-
 
14
 
C-labelled arginine, and another
slower component. The slow component could be non-arginine-
derived-
 
14
 
C, which would not escape the re-utilization problem.
In fact, a small fraction of exogenous carbon is incorporated
into non-arginine amino acids in the liver, and this is similar to
the incorporation in skeletal muscles and intestine (Swick 
 
et
 
 
 
al
 
.,
1953; Swick & Handa, 1956), which do not have complete and
active urea cycle enzymes to convert 
 
14
 
C NaHCO
 
3
 
  to 6-
 
14
 
C
arginine. Accordingly, we found low 
 
14
 
C labels in skeletal muscles
and brain mitochondria, which were similar to each other
(Fig. 2A). Moreover, both the absolute values and the rates of
label decay in muscle and brain mitochondria were very similar
to the estimated slow component in liver mitochondria (estimated
by a two-component decay model). Therefore, we propose to
use data on the slow component obtained from different tissues
of the same animals as a surrogate estimate for the slow
component in the liver. This significantly improves the statistical
power of the obtainable fit in comparison to a two-component
decay model which is fit to liver data alone.
Thus, we describe nonspecific 
 
14
 
C label and its decay in liver
mitochondria (the slow component) by the average of the brain
and muscle 
 
14
 
C counts. Modelling the slow decay in all three
tissues as a linear decrease, i.e. the simplest dynamic model
possible (an exponential decay model changed the results very
little), we obtain:
where µ
 
j
i
 
 (count · mg
 
–1
 
) are the total 
 
14
 
C counts at time 
 
t
 
 (day)
for tissue 
 
i
 
 and experimental condition 
 
j
 
 (control and DR), µ
 
j
0
 
(count · mg
 
–1
 
) represents the value of the exponential ‘fast’
component in the liver at 
 
t
 
 = 0, 
 
k
 
j
d
 
 (day
 
–1
 
) are rate parameters
describing the exponential decay of the specific label (6-
 
14
 
C
arginine) with time in the liver, and 
 
m
 
j
i
 
 (count mg
 
–1
 
 · 
 
t
 
–1
 
) and 
 
c
 
j
i
 
(count · mg
 
–1
 
) are the slope and intercept of the slower linear
processes observed in tissue 
 
i
 
  and experimental condition 
 
j
 
,
respectively. Note that the amount of label in the liver at time
 
t
 
 = 0 (the amount incorporated initially) can be estimated as:
We estimated model parameter values for both control and DR
mice by Bayesian inference using Gibbs sampling (using Markov
chain Monte Carlo methods) as implemented in the OpenBUGS
software package (Thomas 
 
et
 
 
 
al
 
., 2006) with starting conditions
as indicated in the Supporting Information (script available:
http://www.cisban.ac.uk/downloads/Miwa2008.odc). The main
advantage of this method over more traditional ones such as
least squares is that it generates parameter and model estimate
distributions instead of just a single ‘best’ value. This allows us
to test for the significance of differences observed between
treatments (i.e. DR and control). Modelling process dynamics
in all three tissues simultaneously allows us to use information
in the brain and muscle data sets to increase the precision of
Fig. 1 A single exponential decay model is not adequate to measure mouse 
liver mitochondrial half life. (A) Changes in specific activity of 
14C in liver 
mitochondria from control mice with time. Results from two sets of 
independent experiments are shown (full and open circles). Each data point 
represents an individual animal. (B) Effect of chase period on half lives of 
mitochondria from dietary restricted (DR) and control mice. Apparent half 
life time of mitochondria λ depends on the chase period if calculated as single 
exponential decay by logarithmic transfer. Data are mean ± SEM. • = DR; 
❍ = controls. These estimates in control animals are in good agreement with 
published data with corresponding chase periods (Lipsky & Pedersen, 1981; 
Lavie et al., 1982; Saikumar & Kurup, 1985).
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the parameter estimates in the liver model beyond that which
we would have using the liver data alone, and to assess the
difference in liver mitochondrial half lives between control and
DR mice more rigorously.
The simulations fitted the observed data in brain, skeletal
muscle and liver mitochondria from both control and DR mice
very well (Fig. 2a). Posterior half life distributions for the
exponential-decay-component (the fast component, representing
the decay of 6-
 
14
 
C  arginine-dependent labels) in liver are
shown in Fig. 2b. Thus, the estimated median half life of liver
mitochondria is 1.83 days for controls and 1.16 days following
3  months DR, a statistically highly significant difference.
Table S1 (Supporting Information) summarizes the parameter
estimates and their distribution statistics.
Macro-autophagy is the major pathway of mitochondrial
degradation (Kim 
 
et
 
 
 
al
 
., 2007), which is known to be accelerated
by starvation. It has been proposed that DR might act similarly
and, by promoting mitochondrial turnover, maintain a healthy
population of mitochondria (Bergamini 
 
et
 
 
 
al
 
., 2003; Kim 
 
et
 
 
 
al
 
.,
2007). We demonstrate here for the first time that DR animals
indeed have significantly faster rate of liver mitochondrial turn-
over compared with controls. It should be noted, however, that
starvation-induced autophagy is tissue specific. For example,
fasting promoted autophagy in liver and skeletal muscles but
Fig. 2 Liver mitochondrial half life is short and decreases further by 
dietary restriction. (A) Observed (circles) and median simulated (solid 
lines) decay of specific activity of 
14C label in liver (left), muscle (centre) 
and brain (right) mitochondria. Top panels are from 6-month-old control 
mice and the bottom panels are from mice dietary restricted for 
3 months. Dashed lines are 5% and 95% quantiles of samples from 
simulated label count posterior distributions (20 000 simulations 
sampled after discarding 10 000 ‘run-in’ simulations). (B) Posterior 
frequency distributions of calculated half lives (λ
Fast, in days) of liver 
mitochondria from control and dietary restricted mice. In 99.96% of 
the 20 000 sampled simulations λDR < λControl, which is a statistically 
significant result. The median values for λDR and λControl are 1.16 days 
and 1.83 days, respectively. 
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not in brain (Mizushima 
 
et
 
 
 
al
 
., 2004). Thus, it is possible that
increased turnover of mitochondria may be one of the beneficial
mechanisms of DR in liver, but may not necessarily be so in all
cell types.
It should also be noted that the concept of mitochondrial half
life in itself is problematic. First, mitochondria form dynamic
syncytia in cells. Second, macro-autophagy might be selective
(for instance, for damaged mitochondria with low membrane
potential). Third, at least some mitochondrial protein turnover
is mediated by mitochondrial matrix (Lon) proteases (Bulteau
 
et
 
 
 
al
 
., 2006; Ngo & Davies, 2007). Our estimates constitute
averages over all the heterogeneity resulting from these various
processes.
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